Biggest News Aggregation in the World
📰 Membrane Type News

Page 6 - Membrane Type News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Membrane Type. Real-time updates on events, politics, business and more.

Bicycle Therapeutics (NASDAQ:BCYC) Issues Quarterly Earnings Results

Bicycle Therapeutics (NASDAQ:BCYC – Get Rating) issued its earnings results on Thursday. The company reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.25), MarketWatch Earnings reports. Bicycle Therapeutics had a negative return on equity of 35.59% and a negative net margin of 568.71%. Shares of NASDAQ BCYC traded down $1.20 […]
United States Morgan Stanley Northern Trust Corp Zacks Investment Research America Corp Needham Company

Bicycle Therapeutics plc (NASDAQ:BCYC) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have received a consensus rating of “Buy” from the thirteen research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average twelve-month target price among brokerages […]
Dekabank Deutsche Girozentrale Morgan Stanley Vident Investment Advisory Points Wealth Management Zacks Investment Research Blackrock Inc

Bicycle Therapeutics plc (NASDAQ:BCYC) Expected to Announce Quarterly Sales of $3.46 Million

Brokerages expect Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) to report sales of $3.46 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Bicycle Therapeutics’ earnings, with estimates ranging from $2.00 million to $5.10 million. Bicycle Therapeutics posted sales of $1.81 million during the same quarter last year, […]
United States Thomson Reuter Morgan Stanley Northern Trust Corp Zacks Investment Research Highmark Wealth Management

Bicycle Therapeutics plc (NASDAQ:BCYC) Given Consensus Recommendation of "Buy" by Analysts

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have earned an average rating of “Buy” from the eleven ratings firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective […]
Morgan Stanley Vident Investment Advisory Points Wealth Management Goldman Sachs Group Inc Blackrock Inc Needham Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bicycle Therapeutics' (BCYC) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Get Rating) in a report issued on Friday morning, Zacks.com reports. Several other equities research analysts have also commented on the stock. Zacks Investment Research lowered shares of Bicycle Therapeutics from a buy rating to a hold rating in a research note […]
New Jersey United States Morgan Stanley Zacks Investment Research Highmark Wealth Management Jersey Common Pension Fund

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science